cbdMD
YCBD
20 hedge funds and large institutions have $528K invested in cbdMD in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 19 → 20 (+1)
0.55% less ownership
Funds ownership: 5.45% → 4.89% (-0.55%)
42% less capital inflows, than outflows
Capital inflows: $67.7K | Capital outflows: $117K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.3K |
| 2 |
Scientech Research LLC
Jersey City,
New Jersey
|
+$12.6K |
| 3 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
+$9.8K |
| 4 |
Chapin Davis
Baltimore,
Maryland
|
+$2.4K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$539 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$52.7K |
| 2 |
GSA Capital Partners
London,
United Kingdom
|
-$33K |
| 3 |
Virtu Financial
New York
|
-$18K |
| 4 |
Jane Street
New York
|
-$12.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.3K |
YCBD Hedge Fund Activity: Q3 2025 in Review
20 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q3 2025, worth a combined $528K — up 22% from $433K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new YCBD positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $42.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $52.7K sold.
- 20 institutional investors held cbdMD (YCBD) as of Q3 2025, up from 19 in Q2 2025.
- Funds reported $528K of cbdMD stock for Q3 2025, up 22% quarter-over-quarter.
- 5 funds opened new cbdMD positions in Q3 2025 and 4 closed out, a net change of +1 holder.
- The largest cbdMD buyer in Q3 2025 was Vanguard Group, an estimated $42.3K added.
- The largest cbdMD seller in Q3 2025 was Citadel Advisors, an estimated $52.7K sold.
Based on aggregated 13F filings for Q3 2025.